Jean-Francois Leprince
Chief Executive Officer at GLyPharma Therapeutic, Inc.
Network origin in Jean-Francois Leprince first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ.
37
| Subsidiary | Pharmaceuticals: Major | 37 |
Hoechst Marion Roussel, Inc.
18
| Subsidiary | 18 | |
GLyPharma Therapeutic, Inc.
 GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada.
7
| Subsidiary | Biotechnology | 7 |
CTI Capital, Inc.
 CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal.
5
| Subsidiary | Investment Managers | 5 |
ILKOS THERAPEUTICS, Inc.
 ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada.
2
| Holding Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Francois Leprince via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Executive Officer Director/Board Member | |
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member Chief Operating Officer | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| HMR Pharma, Inc. | Sales & Marketing Comptroller/Controller/Auditor | ||
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chairman Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Bioxel Pharma, Inc.
 Bioxel Pharma, Inc. BiotechnologyHealth Technology Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada. | Biotechnology | Chairman Director/Board Member | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
| SANOFI | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
| Rockhurst University | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| McGill University | College/University | Undergraduate Degree Masters Business Admin | |
Fonds de Solidarité FTQ
 Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The Pennsylvania State University | College/University | Masters Business Admin Undergraduate Degree | |
| St. Joseph's University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Tennessee | College/University | Masters Business Admin Doctorate Degree Masters Business Admin | |
| NEPHROGENEX INC | Medical Distributors | Chief Executive Officer Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree | |
| NANOSTRING TECHNOLOGIES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree Doctorate Degree | |
| HEC Montréal | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| HealthCare Institute of New Jersey | Director/Board Member Director/Board Member | ||
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| University of Missouri-Kansas City | College/University | Corporate Officer/Principal Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
Phyxius Pharma, Inc.
 Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Pharmaceuticals: Major | Founder Founder | |
Sanofi-Aventis Groupe SA
 Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Visgenx, Inc.
 Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Biotechnology | Founder Director/Board Member | |
| ANTENGENE CORPORATION LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Boston University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree |
Statistics
International
| United States | 37 |
| Canada | 6 |
| France | 5 |
| Germany | 3 |
| Switzerland | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Finance | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 237 |
| Corporate Officer/Principal | 184 |
| Independent Dir/Board Member | 61 |
| Chief Executive Officer | 57 |
| Chief Tech/Sci/R&D Officer | 55 |
Most connected contacts
| Insiders | |
|---|---|
| Pierre Legault | 45 |
| Norbert Riedel | 29 |
| Frank Douglas | 29 |
| Francois Nader | 28 |
| Mitchell Finer | 26 |
| John Leone | 21 |
| Errol de Souza | 21 |
| Pierre LaPalme | 21 |
| Mark Alles | 20 |
| Martin Zeiger | 19 |
| Gerry Proehl | 19 |
| Shermaine Tilley | 17 |
| Thomas Schuetz | 17 |
| Mark A. Beaudet | 17 |
| Paul Herbert Chew | 15 |
- Stock Market
- Insiders
- Jean-Francois Leprince
- Company connections
